- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05233280
Early Versus Delayed Oral Liquids and Soft Food After Elective Ceasarean Section
February 16, 2022 updated by: Ain Shams University
To compare the safety of early versus delayed oral feeding after uncomplicated cesarean section under spinal anesthesia
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Cesarean section is one of most common surgical procedures saving both for mother and newborn when medically indicated .traditionally
patients are not given fluids or food afer abdominal surgery until bowel function return as evidenced by bowel sounds passage of flatus or stool or feeling of hunger the rationale of this practice is to prevent postoperative nausea , vomiting, distension and other complications
Study Type
Observational
Enrollment (Anticipated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yousra Abdelsattar
- Phone Number: 01001115045
- Email: Yosraabdelsatar@gmail.com
Study Contact Backup
- Name: Magdy Kolib
- Phone Number: 01200520050
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years to 50 years (Child, Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women in child bearing period
Description
Inclusion Criteria:
- previous 1,2,3 cs Uncomplicated elective cs Singletone pregnancy Spinal anesthesia
Exclusion Criteria:
- women with medical disorder HTN, DM History of bowel surgery or intraoprative complication Contraindication to spinal anesthesia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group A
Early feeding group
|
Early versus delayed oral liquid feeding after ceasarean section
|
Group B
Delayed feeding group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time of passage of flatus
Time Frame: 6 hrs
|
6 hrs
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 20, 2022
Primary Completion (Anticipated)
March 15, 2022
Study Completion (Anticipated)
April 15, 2022
Study Registration Dates
First Submitted
January 1, 2022
First Submitted That Met QC Criteria
February 5, 2022
First Posted (Actual)
February 10, 2022
Study Record Updates
Last Update Posted (Actual)
February 18, 2022
Last Update Submitted That Met QC Criteria
February 16, 2022
Last Verified
December 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Oral feeding after ceasarean
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevent Postopertive Nausea and Vomiting
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Spain, Philippines, Israel, Hong Kong, Thailand, United Kingdom, Hungary, Slovenia, Norway, Denmark
-
MonoSol RxCompletedNausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, PostoperativeIndia
-
Hoffmann-La RocheCompletedPost-Operative Nausea and VomitingUnited States
-
Cairo UniversityUnknownPost Operative Nausea and VomitingEgypt
-
Yonsei UniversityCompletedPost Operative Nausea and VomitingKorea, Republic of
-
AccentureCompletedPost-Operative Nausea and Vomiting (PONV)Australia
-
Cairo UniversityCompletedAdenotonsillectomy | Post Operative Nausea and Vomiting (PONV)Egypt
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Hungary, Canada, Spain, Belgium, Germany
-
Methodist Health SystemRecruitingNausea, Postoperative | Vomiting, PostoperativeUnited States
-
Acacia Pharma LtdPremier Research Group plc; Amicus CD LLCRecruitingNausea and Vomiting, PostoperativeCanada, United States, Germany, France
Clinical Trials on Oral liquids and soft food 2 hours postoperative
-
Hôpital Armand TrousseauCompletedReflux, Gastroesophageal | Atopic Dermatitis | Tolerance | Proctocolitis | Food Allergy in InfantsFrance
-
Tong ZhuNot yet recruitingDeep Vein Thrombosis | Deep Venous Insufficiency
-
Vifor PharmaCompleted
-
Sheba Medical CenterUnknown
-
Boehringer IngelheimCompleted
-
Stanford UniversityWashington University School of Medicine; Duke University; University of Washington and other collaboratorsEnrolling by invitation
-
Ottawa Heart Institute Research CorporationHeart and Stroke Foundation of OntarioCompleted
-
PfizerCompleted
-
The University of Texas Health Science Center at...Completed
-
Clarus Therapeutics, Inc.Completed